Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadolinium Texaphyrin + WBRT for Brain Metastases
NCT00003563Phase 3Completed
- Sponsor
- Pharmacyclics
- Start
- Aug 1998
- Primary completion
- Sep 2001
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of motexafin gadolinium in brain metastases, sponsored by Pharmacyclics. Started Aug 1998; status: completed.
02
Drugs
motexafin gadolinium
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00003563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003563.